Stock Track | Haixi Pharma Soars 9.54% Intraday on Share Incentive Plan Announcement and Strong Fundamentals

Stock Track04-30

Haixi Pharma's stock surged 9.54% during intraday trading, showing significant upward momentum in the market session.

The company recently announced the adoption of an H-share incentive plan aimed at establishing a long-term incentive mechanism to align the interests of shareholders, the company, and employees. This announcement, combined with a technical recovery from oversold conditions after the stock had experienced a substantial decline from its historical high, is driving the current rebound.

Fundamentally, Haixi Pharma has reported strong financial performance with revenue increasing 24.79% year-over-year and net profit rising 30.09% for the fiscal year. The company maintains a portfolio of 15 approved generic drugs and is advancing its innovative pipeline, including a drug approaching Phase III clinical trials, contributing to positive investor sentiment.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192464408?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-30 09:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192464408","market":"hk","top_or_hot":-1,"title":"Stock Track | Haixi Pharma Soars 9.54% Intraday on Share Incentive Plan Announcement and Strong Fundamentals","media":"Stock Track","content":"<p>Haixi Pharma's stock surged 9.54% during intraday trading, showing significant upward momentum in the market session.</p><p>The company recently announced the adoption of an H-share incentive plan aimed at establishing a long-term incentive mechanism to align the interests of shareholders, the company, and employees. This announcement, combined with a technical recovery from oversold conditions after the stock had experienced a substantial decline from its historical high, is driving the current rebound.</p><p>Fundamentally, Haixi Pharma has reported strong financial performance with revenue increasing 24.79% year-over-year and net profit rising 30.09% for the fiscal year. The company maintains a portfolio of 15 approved generic drugs and is advancing its innovative pipeline, including a drug approaching Phase III clinical trials, contributing to positive investor sentiment.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Haixi Pharma Soars 9.54% Intraday on Share Incentive Plan Announcement and Strong Fundamentals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Haixi Pharma Soars 9.54% Intraday on Share Incentive Plan Announcement and Strong Fundamentals\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-30 09:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Haixi Pharma's stock surged 9.54% during intraday trading, showing significant upward momentum in the market session.</p><p>The company recently announced the adoption of an H-share incentive plan aimed at establishing a long-term incentive mechanism to align the interests of shareholders, the company, and employees. This announcement, combined with a technical recovery from oversold conditions after the stock had experienced a substantial decline from its historical high, is driving the current rebound.</p><p>Fundamentally, Haixi Pharma has reported strong financial performance with revenue increasing 24.79% year-over-year and net profit rising 30.09% for the fiscal year. The company maintains a portfolio of 15 approved generic drugs and is advancing its innovative pipeline, including a drug approaching Phase III clinical trials, contributing to positive investor sentiment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02637","symbol_name":"海西新药","start_time":0,"source_url":"","article_id":"1192464408","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192464408","pubTimestamp":1777513208,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Haixi Pharma's stock surged 9.54% during intraday trading, showing significant upward momentum in the market session.The company recently announced the adoption of an H-share incentive plan aimed at...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02637":"海西新药"},"translate_title":"个股赛道|海西药业盘中暴涨9.54%股权激励计划公布基本面强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02637":1},"content_text":"Haixi Pharma's stock surged 9.54% during intraday trading, showing significant upward momentum in the market session.The company recently announced the adoption of an H-share incentive plan aimed at establishing a long-term incentive mechanism to align the interests of shareholders, the company, and employees. This announcement, combined with a technical recovery from oversold conditions after the stock had experienced a substantial decline from its historical high, is driving the current rebound.Fundamentally, Haixi Pharma has reported strong financial performance with revenue increasing 24.79% year-over-year and net profit rising 30.09% for the fiscal year. The company maintains a portfolio of 15 approved generic drugs and is advancing its innovative pipeline, including a drug approaching Phase III clinical trials, contributing to positive investor sentiment.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192464408","isCrawlerRequest":true}